Published in Lancet on March 09, 1985
Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion. J Clin Invest (1986) 1.84
Plasma alpha natriuretic peptide in cardiac impairment. Br Med J (Clin Res Ed) (1986) 1.44
Alpha atrial natriuretic peptide concentrations in plasma of children with congenital heart and pulmonary diseases. Br Med J (Clin Res Ed) (1985) 1.40
Plasma atrial natriuretic peptide in patients with acute myocardial infarction: effects of streptokinase. Br Heart J (1989) 1.39
Atrial natriuretic factor in chronic obstructive lung disease with pulmonary hypertension. Physiological correlates and response to peptide infusion. J Clin Invest (1989) 1.19
Blood levels and renal effects of atrial natriuretic peptide in normal man. J Clin Invest (1986) 1.13
Atrial natriuretic factor in human blood. J Clin Invest (1985) 1.10
Estrogen receptors activate atrial natriuretic peptide in the rat heart. Proc Natl Acad Sci U S A (2001) 0.98
Hypoxia regulates the natriuretic peptide system. Int J Physiol Pathophysiol Pharmacol (2011) 0.97
Relationship of increased plasma atrial natriuretic factor and renal sodium handling during immersion-induced central hypervolemia in normal humans. J Clin Invest (1987) 0.93
Prognostic significance of N-terminal pro-atrial natriuretic factor (1-98) in acute myocardial infarction: comparison with atrial natriuretic factor (99-126) and clinical evaluation. Br Heart J (1993) 0.90
Effect of adrenergic and muscarinic cholinergic agonists on atrial natriuretic peptide secretion by isolated rat atria. Potential role of the autonomic nervous system in modulating atrial natriuretic peptide secretion. J Clin Invest (1987) 0.89
Vascular responses to local atrial natriuretic peptide infusion in man. Br J Clin Pharmacol (1988) 0.87
Plasma atrial natriuretic peptide and spontaneous diuresis in sick neonates. Arch Dis Child (1987) 0.87
Vasodilatory actions of alpha-human atrial natriuretic peptide and high Ca2+ effects in normal man. J Clin Invest (1987) 0.86
The renal effects of atrial natriuretic peptide in man are not attenuated by (+)-sulpiride. Br J Clin Pharmacol (1989) 0.84
The renin-angiotensin-aldosterone system and the cardiac natriuretic peptides. Heart (1996) 0.84
Atrial natriuretic peptide in spontaneous tachycardias. Br Heart J (1987) 0.84
Plasma atrial natriuretic factor concentrations in essential and renovascular hypertension. Br Med J (Clin Res Ed) (1987) 0.82
Natriuretic and antikaliuretic effects of uroguanylin and prouroguanylin in the rat. Am J Physiol Renal Physiol (2010) 0.80
The renal, cardiovascular and hormonal actions of human atrial natriuretic peptide in man; effects of indomethacin. Br J Clin Pharmacol (1987) 0.79
Atrial natriuretic peptide in stable and decompensated chronic obstructive pulmonary disease. Thorax (1993) 0.78
Venous responsiveness to atrial natriuretic factor in man. Br J Clin Pharmacol (1988) 0.76
Therapeutic use of atrial natriuretic factor. Br J Clin Pharmacol (1992) 0.76
The heart is an endocrine gland. Trans Am Clin Climatol Assoc (1986) 0.75
Atrial natriuretic factor. West J Med (1986) 0.75
Effect of human atrial natriuretic peptide on blood pressure after sodium depletion in essential hypertension. Br Med J (Clin Res Ed) (1986) 0.75
Atrial natriuretic peptides: clues to their physiological and clinical importance. Postgrad Med J (1987) 0.75
The effect of atrial natriuretic peptide on human isolated resistance arteries. Br J Pharmacol (1989) 0.75
Sponsorship, authorship, and accountability. Lancet (2001) 7.10
Sponsorship, authorship, and accountability. N Engl J Med (2001) 6.20
Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet (2000) 6.01
Sponsorship, authorship and accountability. CMAJ (2001) 5.86
Unsatisfactory redefinition of myocardial infarction. Lancet (2001) 2.89
Aldosterone and its regulation during diuresis in patients with gross congestive heart failure. Clin Sci Mol Med (1974) 2.60
Hepatitis B virus vaccine: identification of HBsAg/a and HBsAg/d but not HBsAg/y subtype antigenic determinants on a synthetic immunogenic peptide. Proc Natl Acad Sci U S A (1982) 2.52
Management of raised blood pressure in New Zealand. N Z Med J (1993) 2.48
The Elag-Koln automatic blood pressure recorder. A clinical appraisal. Br Heart J (1977) 2.34
Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction. Circulation (1998) 2.17
Management of raised blood pressure. N Z Med J (1994) 2.03
Radio-immunoassay for plasma alpha human atrial natriuretic peptide: a comparison of direct and pre-extracted methods. J Hypertens (1987) 1.90
Specificity of the direct solid-phase radioimmunoassay for detection of hepatitis-B antigen. Lancet (1973) 1.89
The prevalence of antibody to hepatitis A antigen in various parts of the world: a pilot study. Am J Epidemiol (1977) 1.86
Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP): a new marker of cardiac impairment. Clin Endocrinol (Oxf) (1997) 1.73
Association of intraluminal thrombus in abdominal aortic aneurysm with local hypoxia and wall weakening. J Vasc Surg (2001) 1.70
Cardiogenic shock treated with infusion of dextrose solution. Am Heart J (1967) 1.69
Effect of eating liquorice on the renin-angiotensin aldosterone axis in normal subjects. Br Med J (1977) 1.68
Mechanical wall stress in abdominal aortic aneurysm: influence of diameter and asymmetry. J Vasc Surg (1998) 1.66
Wall stress distribution on three-dimensionally reconstructed models of human abdominal aortic aneurysm. J Vasc Surg (2000) 1.64
Hypertension, lipoprotein(a), and apolipoprotein A-I as risk factors for stroke in the Chinese. Stroke (1991) 1.61
Diagnostic index for premyxoedema. Lancet (1973) 1.61
Clinical evaluation of perhexiline maleate in patients with angina pectoris. Br Med J (1971) 1.60
Effect of potassium-sparing diuretics on the renin-angiotensin-aldosterone system and potassium retention in heart failure. Br Heart J (1976) 1.59
B-type natriuretic peptide infusions in acute myocardial infarction. Heart (2007) 1.58
Liquorice toxicity and the renin-angiotensin-aldosterone axis in man. Br Med J (1977) 1.56
Effect of extensive debridement and treatment on the healing of diabetic foot ulcers. Diabetic Ulcer Study Group. J Am Coll Surg (1996) 1.55
Effect of sulindac on angiotensin converting enzyme inhibitor-induced cough: randomised placebo-controlled double-blind cross-over study. J Hum Hypertens (1989) 1.55
Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: prognostic utility and prediction of benefit from carvedilol in chronic ischemic left ventricular dysfunction. Australia-New Zealand Heart Failure Group. J Am Coll Cardiol (2001) 1.54
Effect of anticoagulants and storage temperatures on stability of plasma and serum hormones. Clin Biochem (2001) 1.51
Cough with angiotensin converting-enzyme inhibitors. N Z Med J (1987) 1.48
Blood-pressure response to moderate sodium restriction and to potassium supplementation in mild essential hypertension. Lancet (1984) 1.48
Hypertension--still an important cause of heart failure? J Hum Hypertens (2005) 1.46
The syndrome of spontaneous iliac arteriovenous fistula: a distinct clinical and pathophysiologic entity. Surgery (1986) 1.46
Flavone-8-acetic acid (Flavonoid) profoundly reduces platelet-dependent thrombosis and vasoconstriction after deep arterial injury In vivo. Circulation (2000) 1.45
Indirect revascularization of the lower extremity by means of microvascular free-muscle flap--a preliminary report. J Vasc Surg (1990) 1.45
Low-dose growth hormone replacement lowers plasma leptin and fat stores without affecting body mass index in adults with growth hormone deficiency. Clin Endocrinol (Oxf) (1996) 1.45
Plasma alpha natriuretic peptide in cardiac impairment. Br Med J (Clin Res Ed) (1986) 1.44
The nature and prognosis of thyrotoxic heart disease. Q J Med (1985) 1.43
The management of mildly raised blood pressure in New Zealand: an alternative view. N Z Med J (1996) 1.42
A neural mechanism for sudden death after myocardial infarction. Clin Auton Res (2003) 1.41
The use of a toothbrush to debride facial wounds. Br J Plast Surg (1993) 1.40
Congenital long QT syndrome in adults. N Z Med J (1989) 1.39
Cardiac lentiginosis. N Z Med J (1990) 1.39
Simultaneous inflation of tandem (sequential) angioplasty balloons: a means of simultaneously treating multiple lesions in one coronary artery. Cathet Cardiovasc Diagn (1995) 1.39
Assay of brain natriuretic peptide (BNP) in human plasma: evidence for high molecular weight BNP as a major plasma component in heart failure. J Clin Endocrinol Metab (1993) 1.38
Calorie-restricted weight reduction, blood pressure, and atrial natriuretic peptides. Nutrition (1993) 1.38
Sulindac and cough induced by converting enzyme inhibitors. Lancet (1987) 1.38
Treatment of severe orthostatic hypotension with the somatostatin analogue octreotide. Aust N Z J Med (1990) 1.37
Ex vivo biomechanical behavior of abdominal aortic aneurysm: assessment using a new mathematical model. Ann Biomed Eng (1997) 1.35
EXTRAUTERINE GESTATION AT TERM WITH HEALTHY BABY. Br Med J (1929) 1.34
The amino-terminal portion of pro-brain natriuretic peptide (Pro-BNP) circulates in human plasma. Biochem Biophys Res Commun (1995) 1.33
Outcome events in patients with claudication: a 15-year study in 2777 patients. J Vasc Surg (2001) 1.31
Bioactivity and metabolism of C-type natriuretic peptide in normal man. J Clin Endocrinol Metab (1994) 1.29
High concentrations of thyroid-stimulating hormone in untreated glucocorticoid deficiency: indication of primary hypothyroidism? Br Med J (Clin Res Ed) (1982) 1.28
Management of splenic artery aneurysms: the significance of portal and essential hypertension. J Am Coll Surg (1999) 1.28
Mechanical properties and microstructure of intraluminal thrombus from abdominal aortic aneurysm. J Biomech Eng (2001) 1.28
Haemodynamic, hormonal, and electrolyte responses to captopril in resistant heart failure. Lancet (1981) 1.26
Decrease in cardiac output and muscle sympathetic activity during vasovagal syncope. Am J Physiol Heart Circ Physiol (2002) 1.24
Hemodynamic and hormonal responses during captopril therapy for heart failure: acute, chronic and withdrawal studies. Am J Cardiol (1982) 1.22
Sponsorship, authorship, and accountability. JAMA (2001) 1.22
Renal, endocrine, and hemodynamic effects of human brain natriuretic peptide in normal man. J Clin Endocrinol Metab (1993) 1.21
Hyponatremic-hypertensive syndrome with renal ischemia: an underrecognized disorder. Hypertension (1999) 1.20
Brain natriuretic factor: regional plasma concentrations and correlations with haemodynamic state in cardiac disease. Br Heart J (1993) 1.19